Gavin Newsom, Pharma Baron: The California Governor has some insulin to sell you—and it’s no bargain

WSJ editorial. Excerpts:

"The state is chasing the leading insulin manufacturers, which have capped out-of-pocket costs for patients at $35 for a month’s supply. Patients will pay more for California’s generic than for similar insulins already on the market."

"Mr. Newsom at first wanted to manufacture insulin in the state. When this proved too challenging, he pivoted in 2023 to contract with nonprofit generic manufacturer Civica Rx, which was founded by large hospitals and philanthropies. He claimed this drug-making partnership would reduce the insulin price by 90%."

"the typical patient in 2019 paid $9 per insulin prescription. Only 20% of patients paid more than $70 in 2019"

"all Americans regardless of insurance can get a month’s supply of insulin for $35."